SynthesisJournal of neurology2026

Reassessing the adverse event profiles of levetiracetam and brivaracetam: a systematic review and meta-analysis.

Emma Fröling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.